Baxion
Screening
Tags
Alerts
Theme
Envveno Medical Corporation
NVNO
·
NASDAQ
·
$11.25
Share Price as of 11/2
·
$185,657
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q3 ended 09/30/26
10/29/26
10-Q
Q2 ended 06/30/26
07/30/26
10-Q
Q1 ended 03/31/26
05/06/26
10-K
FY 2025
03/26/26
10-Q
Q3 ended 09/30/25
10/30/25
Disclosures
Filter
8-K
Current report
07/14/26
8-K
Current report
04/29/26
8-K
Current report
02/04/26
8-K
Current report
01/20/26
8-K
Current report
12/12/25
Prospectuses and Registrations
Filter
S-3
Shelf registration
08/21/26
S-8
Registration of securities for employees
03/26/26
424B5
Prospectus supplement
10/30/25
S-3/A
Shelf registration (amended)
03/12/25
S-8
Registration of securities for employees
03/12/25
Proxies
Filter
DEF 14A
Definitive proxy
10/29/26
DEFA14A
Additional proxy materials
10/29/26
DEFR14A
Definitive proxy (revised)
12/02/25
PRER14A
Preliminary proxy (revised)
11/19/25
DEF 14A
Definitive proxy
10/30/25
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
09/15/26
Form 4
Insider transaction
09/14/26
144
Proposed sale of securities
09/11/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
Form 4
Insider transaction
06/12/26
Other
Filter
CORRESP
Correspondence with the SEC
03/14/25
EFFECT
Request for effectiveness
03/14/25
UPLOAD
Letter from the SEC
03/10/25
EFFECT
Request for effectiveness
11/03/23
CORRESP
Correspondence with the SEC
11/01/23
Latest Filings
Filter
10-Q
Q3 ended 09/30/26
10/29/26
DEF 14A
Definitive proxy
10/29/26
DEFA14A
Additional proxy materials
10/29/26
S-3
Shelf registration
08/21/26
10-Q
Q2 ended 06/30/26
07/30/26
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
09/15/26
Form 4
Insider transaction
09/14/26
144
Proposed sale of securities
09/11/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
Form 4
Insider transaction
06/12/26